Cost-Effectiveness of Glaucoma Interventions in Barbados and Ghana

被引:30
|
作者
Wittenborn, John S. [1 ]
Rein, David B. [1 ]
机构
[1] RTI Int, Publ Hlth Econ Program, Res Triangle Pk, NC 27709 USA
关键词
glaucoma; vision; simulation; cost effective; developing; Ghana; Barbados; OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; VISUAL IMPAIRMENT; EYE; PROGRESSION; PREVALENCE; PERSISTENCY; POPULATION; REDUCTION; TRIAL;
D O I
10.1097/OPX.0b013e3181fc30f3
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. More than 90% of blindness worldwide exists in the developing world, but information on the social and economic burden and the cost-effectiveness of treatment in these settings is often limited or nonexistent. We demonstrate the use of computer modeling to simulate the current and future epidemiology, outcomes, and treatment of primary open-angle glaucoma in high-incidence populations of the developing world. Methods. A previously validated vision model was modified to simulate the incidence progression and social and economic outcomes of glaucoma in Barbados, which was the source of epidemiology data, and Ghana, which has similar propensity for glaucoma but lower socioeconomic development. We then assessed the cost-effectiveness of hypothetical case-finding and treatment scenarios, including U. S. guideline-level care and one-time laser surgery. Results. Barbados incurs relatively greater social and economic burden from glaucoma than Ghana. In Barbados, population screening followed by U. S. guideline levels of care appears to be highly cost-effective. Because of a younger population with higher mortality at younger ages, glaucoma appears to cause less visual impairment and blindness in Ghana than in Barbados, resulting in lower per capita disability and productivity losses. Population screening or guideline-level treatment scenarios were generally not cost-effective in Ghana, but treating self-referring patients with a hypothetical one-time laser surgery was highly cost-effective relative to World Health Organization willingness to pay thresholds. Conclusions. The social and economic burden of glaucoma is higher in developed nations because of increased life expectancy, an older population age profile, and higher per capita gross domestic product. Similarly, lower mortality rates and higher per capita gross domestic product increase the relative cost-effectiveness of screening and treatment interventions intended to mitigate glaucoma burden. (Optom Vis Sci 2011; 88: 155-163)
引用
收藏
页码:155 / 163
页数:9
相关论文
共 50 条
  • [1] Glaucoma Care Cost-Effectiveness
    Hoskins, H. Dunbar, Jr.
    [J]. OPHTHALMOLOGY, 2009, 116 (05) : 1016 - 1016
  • [2] COST-EFFECTIVENESS OF ANTITUBERCULOSIS INTERVENTIONS
    CASTELO, A
    MATHIASI, PA
    IUNES, R
    KRITSKI, AL
    DALCOLMO, M
    DEMELO, FF
    DRUMMOND, M
    [J]. PHARMACOECONOMICS, 1995, 8 (05) : 385 - 399
  • [3] COST-EFFECTIVENESS OF OBESITY INTERVENTIONS
    Veerman, Lennert
    Sacks, Gary
    Lee, Yong-Yi
    Cobiac, Linda
    Barendregt, Jan
    Vos, Theo
    Carter, Rob
    [J]. INTERNAL MEDICINE JOURNAL, 2013, 43 : 20 - 20
  • [4] Cost-effectiveness of coronary interventions
    Cohen, DJ
    Sukin, CA
    [J]. HEART, 1997, 78 : 7 - 10
  • [5] GLAUCOMA SCREENING - A COST-EFFECTIVENESS ANALYSIS
    GOTTLIEB, LK
    SCHWARTZ, B
    PAUKER, SG
    [J]. SURVEY OF OPHTHALMOLOGY, 1983, 28 (03) : 206 - 228
  • [6] The comparative effectiveness and cost-effectiveness of vitreoretinal interventions
    Brown, Melissa M.
    Brown, Gary C.
    Brown, Heidi C.
    Irwin, Blair
    Brown, Kathryn S.
    [J]. CURRENT OPINION IN OPHTHALMOLOGY, 2008, 19 (03) : 202 - 207
  • [7] Effectiveness; and cost-effectiveness of antidepressants and psychological interventions
    Perestelo-Perez, Lilisbeth
    Garcia-Perez, Lidia
    Penate-Castro, Wenceslao
    de las Cuevas-Castresana, Carlos
    [J]. INTERNATIONAL JOURNAL OF PSYCHOLOGY, 2008, 43 (3-4) : 649 - 649
  • [8] Remote Health Interventions: Effectiveness, Cost, and Cost-Effectiveness Considerations
    Williams, Austin M.
    Gift, Thomas L.
    [J]. SEXUALLY TRANSMITTED DISEASES, 2022, 49 (11S) : S15 - S17
  • [9] Cost-effectiveness of therapeutic interventions in schizophrenia
    Diaz-Castro, L.
    Cabello-Rangel, H.
    Arredondo, A.
    de Leon, E. Madrigal
    Pineda-Antunezc, C.
    [J]. EUROPEAN JOURNAL OF PSYCHIATRY, 2017, 31 (01): : 11 - 16
  • [10] Behavioral interventions and cost-effectiveness analysis
    Wagner, TH
    Goldstein, MK
    [J]. PREVENTIVE MEDICINE, 2004, 39 (06) : 1208 - 1214